Paper2936747
Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2'-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model.
Bartkowski R and 7 others. J Cancer Res Clin Oncol, 1986. Cited by 57 papers, by iCite.
Cite this record
ConductScience Library. Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2'-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model. Papers, record 2936747. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2936747
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2'-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Floxuridine | Major topic |
| Fluorouracil | Major topic |
| Liver Neoplasms | Major topic |
| Liver Neoplasms, Experimental | Major topic |
| Animals | |
| DNA, Neoplasm | |
| Liver | |
| Rats |
Source PubMed
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 42176 | Standardization of the alkaline elution procedure using X-ray-damaged nuclear DNA. | Tumori | 1979 | https://conductscience.org/library/papers/42176 | PubMed |
| 2 | 6647987 | Pharmacokinetics of intra-arterial chemotherapy. | Recent Results Cancer Res | 1983 | https://conductscience.org/library/papers/6647987 | PubMed |
| 3 | 939235 | Treatment of experimental liver tumors by continuous intra-arterial chemotherapy. | Eur J Cancer (1965) | 1976 | https://conductscience.org/library/papers/939235 | PubMed |
| 5 | 151583 | A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. | Cancer Res | 1978 | https://conductscience.org/library/papers/151583 | PubMed |
| 6 | 6648014 | Transient repeated dearterialization combined with intra-arterial infusion of oncolytic drugs in the treatment of liver tumors. | Recent Results Cancer Res | 1983 | https://conductscience.org/library/papers/6648014 | PubMed |
| 7 | 13776896 | A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. | Radiat Res | 1961 | https://conductscience.org/library/papers/13776896 | PubMed |
| 8 | 6648012 | Chemoembolization: a new treatment for malignant tumors and metastases. | Recent Results Cancer Res | 1983 | https://conductscience.org/library/papers/6648012 | PubMed |
| 9 | 6713387 | Incorporation of 5-fluorouracil into murine bone marrow DNA in vivo. | Cancer Res | 1984 | https://conductscience.org/library/papers/6713387 | PubMed |
| 10 | 94515 | Improved microfluorometric DNA determination in biological material using 33258 Hoechst. | Anal Biochem | 1979 | https://conductscience.org/library/papers/94515 | PubMed |
| 11 | 6263474 | Totally implanted drug delivery system for hepatic arterial chemotherapy. | Cancer Treat Rep | 1981 | https://conductscience.org/library/papers/6263474 | PubMed |
| 12 | 1157835 | Erythroid progenitors in mouse bone marrow detected by macroscopic colony formation in culture. | Exp Hematol | 1975 | https://conductscience.org/library/papers/1157835 | PubMed |
| 13 | 558823 | DNA damage and repair in mouse leukemia L1210 cells treated with nitrogen mustard, 1,3-bis(2-chloroethyl)-1-nitrosourea, and other nitrosoureas. | Cancer Res | 1977 | https://conductscience.org/library/papers/558823 | PubMed |
| 14 | 6799160 | Cancer statistics, 1982. | CA Cancer J Clin | 1982 | https://conductscience.org/library/papers/6799160 | PubMed |
| 15 | 6648018 | Isolated liver perfusion in dogs. | Recent Results Cancer Res | 1983 | https://conductscience.org/library/papers/6648018 | PubMed |
| 16 | 5402533 | The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to "small" and "large" tumors. | Surgery | 1969 | https://conductscience.org/library/papers/5402533 | PubMed |
| 17 | 6648019 | First experimental and clinical results of isolated liver perfusion with cytotoxics in metastases from colorectal primary. | Recent Results Cancer Res | 1983 | https://conductscience.org/library/papers/6648019 | PubMed |
| 18 | 4284139 | Vascular distribution of hepatic tumors. Experimental study. | Rev Int Hepatol | 1965 | https://conductscience.org/library/papers/4284139 | PubMed |
| 20 | 6458299 | The incorporation of 5-fluoro-2'-deoxyuridine into DNA of mammalian tumor cells. | Biochem Biophys Res Commun | 1981 | https://conductscience.org/library/papers/6458299 | PubMed |
| 21 | 6648016 | Improved quality of life with an implantable pump for liver perfusion. | Recent Results Cancer Res | 1983 | https://conductscience.org/library/papers/6648016 | PubMed |
| 22 | 2936747 | Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2'-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model. | J Cancer Res Clin Oncol | 1986 | https://conductscience.org/library/papers/2936747 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42306790 | Balloon-occluded hepatic arterial infusion for unresectable hepatocellular carcinoma: a phase II trial interim analysis. | Front Oncol | 2026 | https://conductscience.org/library/papers/42306790 | PubMed |
| 42168880 | Comparative safety and efficacy of hepatic arterial infusion chemotherapy combined with targeted therapy and immunotherapy, with or without transarterial chemoembolization, in unresectable hepatocellular carcinoma: a multicenter retrospective cohort study. | BMC Gastroenterol | 2026 | https://conductscience.org/library/papers/42168880 | PubMed |
| 41983220 | Phase II trial of hepatic arterial infusion chemotherapy plus bevacizumab and toripalimab for advanced biliary tract cancers: efficacy, safety, and exploratory analysis. | Hepatobiliary Surg Nutr | 2026 | https://conductscience.org/library/papers/41983220 | PubMed |
| 41383565 | Case Report: Successful Surgical Resection of PVTT Vp4 Hepatocellular Carcinoma Following Hepatic Arterial Infusion Chemotherapy Combined with Cadonilimab Plus Donafenib. | Pharmgenomics Pers Med | 2025 | https://conductscience.org/library/papers/41383565 | PubMed |
| 40302359 | A Contrast-Enhanced Ultrasound Cine-Based Deep Learning Model for Predicting the Response of Advanced Hepatocellular Carcinoma to Hepatic Arterial Infusion Chemotherapy Combined With Systemic Therapies. | Cancer Sci | 2025 | https://conductscience.org/library/papers/40302359 | PubMed |
| 40287734 | Predictive factors and prognostic models for Hepatic arterial infusion chemotherapy in Hepatocellular carcinoma: a comprehensive review. | World J Surg Oncol | 2025 | https://conductscience.org/library/papers/40287734 | PubMed |
| 39234395 | Efficacy and safety of hepatic arterial infusion chemotherapy combined with fruquintinib and tislelizumab for patients with microsatellite stable colorectal cancer liver metastasis following failure of multiple-line therapy. | Front Oncol | 2024 | https://conductscience.org/library/papers/39234395 | PubMed |
| 38911293 | PD-1 Inhibitors Combined with Tyrosine Kinase Inhibitors with or without Hepatic Artery Infusion Chemotherapy for the First-Line Treatment of HBV-Related Advanced Hepatocellular Carcinoma: A Retrospective Study. | J Hepatocell Carcinoma | 2024 | https://conductscience.org/library/papers/38911293 | PubMed |
| 38686567 | Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein-1 inhibitors: A promising treatment approach for high-burden hepatocellular carcinoma. | Cancer Med | 2024 | https://conductscience.org/library/papers/38686567 | PubMed |
| 38678485 | Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study. | Abdom Radiol (NY) | 2024 | https://conductscience.org/library/papers/38678485 | PubMed |
| 38425407 | Progress in the treatment of advanced hepatocellular carcinoma with immune combination therapy. | World J Gastrointest Oncol | 2024 | https://conductscience.org/library/papers/38425407 | PubMed |
| 38393621 | Development and Preliminary Validation of a Novel Convolutional Neural Network Model for Predicting Treatment Response in Patients with Unresectable Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy. | J Imaging Inform Med | 2024 | https://conductscience.org/library/papers/38393621 | PubMed |
| 38384459 | Clinical and biomarker analyses of hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitor for patients with advanced intrahepatic cholangiocarcinoma. | Front Immunol | 2024 | https://conductscience.org/library/papers/38384459 | PubMed |
| 38282664 | Techniques and status of hepatic arterial infusion chemotherapy for primary hepatobiliary cancers. | Ther Adv Med Oncol | 2024 | https://conductscience.org/library/papers/38282664 | PubMed |
| 37864725 | Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations. | Hepatol Int | 2024 | https://conductscience.org/library/papers/37864725 | PubMed |
| 36132426 | Hepatic Arterial Infusion Chemotherapy as a Timing Strategy for Conversion Surgery to Treat Hepatocellular Carcinoma: A Single-Center Real-World Study. | J Hepatocell Carcinoma | 2022 | https://conductscience.org/library/papers/36132426 | PubMed |
| 35920966 | Comparison of Arterial Infusion Chemotherapy and Chemoembolization for Locally Advanced Hepatocellular Carcinoma: a Multicenter Retrospective Study. | J Gastrointest Surg | 2022 | https://conductscience.org/library/papers/35920966 | PubMed |
| 35582475 | Hepatic arterial infusion of oxaliplatin plus raltitrexed in unresectable hepatocellular carcinoma with or without portal vein tumour thrombosis. | Gastroenterol Rep (Oxf) | 2022 | https://conductscience.org/library/papers/35582475 | PubMed |
| 35070063 | Neoadjuvant treatment strategies for hepatocellular carcinoma. | World J Gastrointest Surg | 2021 | https://conductscience.org/library/papers/35070063 | PubMed |
| 33083282 | Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma. | Liver Cancer | 2020 | https://conductscience.org/library/papers/33083282 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2936747
GET https://conductscience.org/api/papers/v1/2936747/cited_by?page=2